Tuberculosis treatment

Rabahi, Marcelo Fouad; Silva Júnior, José Laerte Rodrigues da; Ferreira, Anna Carolina Galvão; Tannus-Silva, Daniela Graner Schuwartz; Conde, Marcus Barreto.
J. bras. pneumol ; 43(6): 472-486, Nov.-Dec. 2017. tab
Artigo em Inglês | LILACS | ID: biblio-893876

Documentos relacionados

  1. Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States.
  2. Complete sputum smear monitoring among adults with pulmonary tuberculosis in central Uganda: evidence from a retrospective cohort study.
  3. Tuberculosis treatment.
  4. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies.
  5. Tuberculosis treatment outcomes and associated factors in two states in Nigeria.
  6. Sex and Gender Differences in Tuberculosis Pathogenesis and Treatment Outcomes.
  7. A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
  8. [The performance of health services in providing DOTs in households to control tuberculosis].
  9. Performance of the MeltPro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection.
  10. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis.